Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H8OS3 |
Molecular Weight | 240.365 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=CC(=S)SS2
InChI
InChIKey=KYLIZBIRMBGUOP-UHFFFAOYSA-N
InChI=1S/C10H8OS3/c1-11-8-4-2-7(3-5-8)9-6-10(12)14-13-9/h2-6H,1H3
Molecular Formula | C10H8OS3 |
Molecular Weight | 240.365 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/1327842Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19957670
Sources: http://www.ncbi.nlm.nih.gov/pubmed/1327842
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19957670
Anethole trithione or anetholtrithione is a drug used in the treatment of dry mouth. Anethole trithione is a bile secretion-stimulating drug that restores salivation. It is listed in the U.S. National Cancer Institute's Dictionary of Cancer Terms as being studied in the treatment of cancer. Anethol has also been identified as a treatment for improving medium and severe dry eye symptoms. The mechanism of action for the chemopreventive and xerostomia properties have not been fully elucidated.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3196385
Curator's Comment: Known to be CNS NON-penetrant in mouse. Human data not available.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effects of chronic anethole trithione and amitriptyline treatment on rat parotid gland signalling. | 1992 May 12 |
|
Chemoprevention of colon carcinogenesis by organosulfur compounds. | 1993 Aug 1 |
|
Inhibition of NF-kappa B activation in human T-cell lines by anetholdithiolthione. | 1996 Jan 5 |
|
Assessment of the role of glutathione conjugation in the protection afforded by anethol dithiolthione against hexachloro-1,3-butadiene-induced nephrotoxicity. | 1996 Jul |
|
Chemopreventive efficacy of anethole trithione, N-acetyl-L-cysteine, miconazole and phenethylisothiocyanate in the DMBA-induced rat mammary cancer model. | 1997 Jul 3 |
|
Protective effects of anethole dithiolethione against oxidative stress-induced cytotoxicity in human Jurkat T cells. | 1998 Jul 1 |
|
Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial. | 1999 Sep |
|
Anethole dithiolethione regulates oxidant-induced tyrosine kinase activation in endothelial cells. | 2000 Winter |
|
Lens epithelial cell protection by aminothiol WR-1065 and anetholedithiolethione from ionizing radiation. | 2001 |
|
Kinetic constraints for the thiolysis of 4-methyl-5-(pyrazin-2-yl)-1,2-dithiole-3-thione (oltipraz) and related dithiole-3-thiones in aqueous solution. | 2001 Aug |
|
Enhancement of salivary secretion and neuropeptide (substance P, alpha-calcitonin gene-related peptide) levels in saliva by chronic anethole trithione treatment. | 2001 Dec |
|
A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. | 2002 Jul 3 |
|
The neuroprotective antioxidant alpha-lipoic acid induces detoxication enzymes in cultured astroglial cells. | 2002 Jun |
|
Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features. | 2002 Jun |
|
[Radiation protectants of the crystalline lens]. | 2003 Nov |
|
Seizures in the developing brain. | 2004 |
|
[Anethole dithiolethione: an antioxidant agent against tenotoxicity induced by fluoroquinolones]. | 2004 Jul |
|
[A case of pneumatosis cystoides intestinalis developed in a patient with Sjogren syndrome during administration of anetholetrithion]. | 2005 Jul |
|
The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes. | 2006 May |
|
HPLC determination of anethole trithione and its application to pharmacokinetics in rabbits. | 2006 Nov 16 |
|
Determination of anethole trithione in human plasma using high performance liquid chromatography coupled with tandem mass spectrometric detection. | 2007 Jul 2 |
|
Tissue specific increase of the catalytic subunits of the 26S proteasome by indirect antioxidant dithiolethione in mice: enhanced activity for degradation of abnormal protein. | 2007 Jun 6 |
|
Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. | 2007 May |
|
HPLC determination of 4-hydroxy-anethole trithione in plasma via enzymatic hydrolysis and its application to bioequivalence study. | 2008 Jul 15 |
|
New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity. | 2008 Mar 15 |
|
Cancer is a preventable disease that requires major lifestyle changes. | 2008 Sep |
|
[The clinical therapic efficiency of anethol trithione on dry eye]. | 2009 Jun |
|
Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation. | 2009 Sep 8 |
|
Design, synthesis, and pharmacological evaluation of the aqueous prodrugs of desmethyl anethole trithione with hepatoprotective activity. | 2010 Jul |
|
Quantitative morphometry of respiratory tract epithelial cells as a tool for testing chemopreventive agent efficacy. | 2010 Mar |
|
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. | 2010 May |
|
Modulation of thiol homeostasis induced by H2S-releasing aspirin. | 2010 May 1 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10487404
was administered 6 tablets per day
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/11213483
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:10 GMT 2023
by
admin
on
Fri Dec 15 15:04:10 GMT 2023
|
Record UNII |
QUY32964DJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C54630
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
||
|
WHO-ATC |
A16AX02
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
||
|
WHO-VATC |
QA16AX02
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2194
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
m1907
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL178862
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
100000077420
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
208-528-5
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
Anethole trithione
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
QUY32964DJ
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
DTXSID9046651
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
532-11-6
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
DB13853
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
D000781
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
820
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | RxNorm | ||
|
C246
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
SUB12902MIG
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY | |||
|
218
Created by
admin on Fri Dec 15 15:04:10 GMT 2023 , Edited by admin on Fri Dec 15 15:04:10 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MINOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
MAJOR
|
||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |